JP2024500912A5 - - Google Patents
Info
- Publication number
- JP2024500912A5 JP2024500912A5 JP2023538150A JP2023538150A JP2024500912A5 JP 2024500912 A5 JP2024500912 A5 JP 2024500912A5 JP 2023538150 A JP2023538150 A JP 2023538150A JP 2023538150 A JP2023538150 A JP 2023538150A JP 2024500912 A5 JP2024500912 A5 JP 2024500912A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063128922P | 2020-12-22 | 2020-12-22 | |
| US63/128,922 | 2020-12-22 | ||
| US202163192854P | 2021-05-25 | 2021-05-25 | |
| US63/192,854 | 2021-05-25 | ||
| US202163220182P | 2021-07-09 | 2021-07-09 | |
| US63/220,182 | 2021-07-09 | ||
| US202163285513P | 2021-12-03 | 2021-12-03 | |
| US63/285,513 | 2021-12-03 | ||
| PCT/EP2021/086689 WO2022136209A1 (en) | 2020-12-22 | 2021-12-20 | Interleukin 5 binding protein dosage regimen |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024500912A JP2024500912A (ja) | 2024-01-10 |
| JPWO2022136209A5 JPWO2022136209A5 (https=) | 2024-12-18 |
| JP2024500912A5 true JP2024500912A5 (https=) | 2024-12-18 |
Family
ID=86732980
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023538150A Pending JP2024500912A (ja) | 2020-12-22 | 2021-12-20 | インターロイキン５結合タンパク質の投与レジメン |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240043524A1 (https=) |
| EP (2) | EP4644416A3 (https=) |
| JP (1) | JP2024500912A (https=) |
| CA (1) | CA3199805A1 (https=) |
| ES (1) | ES3057414T3 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026078117A1 (en) * | 2024-10-11 | 2026-04-16 | Glaxosmithkline Intellectual Property Development Limited | Anti-il-5 antibody in the treatment of chronic rhinosinusitis with nasal polyps |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2699293B8 (en) * | 2011-04-20 | 2022-07-20 | Amgen Inc. | Autoinjector apparatus |
| CA2921927A1 (en) * | 2013-08-19 | 2015-02-26 | Dr. Reddy's Laboratories, Ltd. | Selectable single dose auto-injector and methods of making and using same |
| TWI799417B (zh) * | 2017-05-26 | 2023-04-21 | 英商葛蘭素史克智慧財產發展有限公司 | 生物製藥組成物及相關方法 |
| CA3064859A1 (en) * | 2017-06-06 | 2018-12-13 | Glaxosmithkline Llc | Biopharmaceutical compositions and methods for pediatric patients |
| US11613571B2 (en) * | 2018-05-23 | 2023-03-28 | Glaxosmithkline Intellectual Property Development Limited | Biopharmaceutical compositions comprising antibody variants |
-
2021
- 2021-12-20 ES ES21844228T patent/ES3057414T3/es active Active
- 2021-12-20 CA CA3199805A patent/CA3199805A1/en active Pending
- 2021-12-20 EP EP25195590.2A patent/EP4644416A3/en active Pending
- 2021-12-20 US US18/258,588 patent/US20240043524A1/en active Pending
- 2021-12-20 EP EP21844228.3A patent/EP4267184B1/en active Active
- 2021-12-20 JP JP2023538150A patent/JP2024500912A/ja active Pending